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Purpose: The purpose of our study is to investigate the presence of anemia
among patients admitted for acute heart failure and to evaluate its short and
medium term prognostic value.
Methods: This is a retrospective study of 234 patients admitted in the car-
diology department of Fattouma Bourguiba Monastir hospital between Jan-
uary 2010 and March 2011. Anemia was defined according to the criteria of
the World Health Organization (WHO): Haemoglobin <13g/dl in men and
<12g/dl in women.
Results: The mean hemoglobin (Hb) was 12.1±2.26g / dl. The prevalence
of anemia in our population is 55.6% (N=130 cases). A significantly higher
frequency of anemia is found among subjects older than 75 years (71.18% vs
50.28%, P=0.005), patients with impaired renal function (72.46% vs 48.48%,
p=0.001) and among those who had shown signs of right heart failure (72.18%
vs. 48.48%, p=0.001) whereas no statistically significant difference was found
among hypertensive diabetics or those with impaired LVEF.
17 of our patients died during hospitalization. 10 Among these patients had
anemia. The relative increase in hospital mortality in anemic patients was not
significant. Nevertheless, the rate of rehospitalization during follow-up of
6 months and the rate of mortality at 6 months were significantly higher in
patients who had anemia; Respectively 14.28% vs 3.68%, p=0.001 and 7.83%
vs 3.68% p=0.019.
Conclusion: Anemia is frequent in patients admitted for acute heart failure
and seems to be related to an increase in readmission and mortality at
6 months in our study. 
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Purpose: The aims of this study is to characterize hyponatremic hospital-
ized patients with HF and to clarify the relations between hyponatremia and
outcomes during hospitalization and at 6 months.
Methods: This is a retrospective study of 234 patients admitted in the
cardiology department of Fattouma Bourguiba Monastir hospital between
January 2010 and March 2011. 
Hyponatremia was defined as a blood value of sodium < 135 mmol/l.
Results: The mean serum sodium concentration is 138±5 mmol / l. Hypo-
natremia (Na + <135 mmol / l) was noted in 63 (26.9%) patients.
Hospital mortality was 7.3% (N = 17). Cardiovascular origin was observed
in 58.8% of cases. This mortality was significantly higher in patients with
hyponatremia, 15.87%, compared to 4.09%, in those with normonatremia
(p=0.004). After their outputs, 39 patients (19.69%) required at least one re-
hospitalization during the first 6 months of follow-up. The 6-month mortality
was 11, 5%. The rate of readmission and mortality at 6 months was higher in
patients who had hyponatremia; respectively 32.07% vs 13.41%, p =0.002 and
21.42% vs 7.78%, p =0.005.
Conclusion: In our study, the presence of hyponatremia in patients hospi-
talized for acute heart failure is predictive of hospital mortality, readmission
and mortality at 6 months. 
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Heart failure (HF) is a frequent and severe comorbidity in dialysis patients
(pts); conversely, 30% of pts in the large Acute Decompensated Heart Failure
National Registry had moderate to severe chronic kidney disease and 5% were
receiving dialysis therapy. Refractory HF is a not uncommon indication for
peritoneal ultrafiltration although its benefits have been unconsistently
reported through mainly retrospective or monocentric studies. The main objec-
tives of the “heart module” are to prospectively collect data related to cardiac
status in PD pts and to allow longitudinal follow-up of cardiac- and dialysis-
related parameters in HF pts 
Methods: The RDPLF constitutes the largest recruiting observational
cohort of French speaking PD pts, with coverage estimated at 98,3% of PD in
France in 2013. All centers complete a set of core modules covering socio-
demographics and basic clinical information, peritonitis episodes, and out-
comes. Optional specialized modules are available. The heart module consists
of baseline followed by quarterly collection of information related to cardiac
disease, hospitalization rate, and dialysis-related parameters.
Results: 14 centers volunteered to participate since the heart module was
launched in February 2013, now totalizing 75 pts. PD was initiated because of
HF in 73%. Mean eGFR was 22±14ml/mn/1.73m2 with GFR>15ml/mn/
1.73m2 in 69%. Half of the pts had echocardiographic Left Ventricular Ejec-
tion Fraction (LVEF)<30% and 71% pts had NYHA III-IV status. Mean rate
of hospitalization the previous year was 30.8 days/pts/yr. Follow-up data were
obtained in 38 pts at 3 months. Hospitalization rate decreased from 8.4 days/
100 days to 4.7 days/100 days. LVEF increased by more than 10% in 13/
23 pts. Mortality rate was 15.6% among the 32 pts with 1-year follow-up. 
Conclusions: Expanding this cohort will give the unique opportunity to
define features of HF requiring PD and clarify which pts take most benefit
from the strategy. The rapid decrease of hospitalization rate is confirmatory of
previous studies.
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Acute kidney injury (AKI) is frequent during acute heart failure (AHF) and
worsens the outcome. To predict AKI is important but remains challenging.
The aim of this study was to analyze Doppler-derived renal arterial resistance
index (RRI) during AHF as well as its determinants and its predictive value of
AKI as compared to renal biomarkers
Methods: comprehensive echocardiographic examination and Doppler
measurement of RRI were performed on admission, at day 3 and at discharge.
RRI was the ratio (peak systolic velocity – end diastolic velocity)/ peak sys-
tolic velocity of interlobar blood flow. Serial assessment of clinical parameters
